Skip to main content
Top
Published in: Diabetologia 11/2007

01-11-2007 | Article

The relationship of retinal vascular calibre to diabetes and retinopathy: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study

Authors: G. Tikellis, J. J. Wang, R. Tapp, R. Simpson, P. Mitchell, P. Z. Zimmet, J. Shaw, T. Y. Wong

Published in: Diabetologia | Issue 11/2007

Login to get access

Abstract

Aims/hypothesis

The aim of the study was to examine the relationship of retinal vascular calibre with glucose intolerance, diabetes and retinopathy in a population-based cohort.

Methods

The Australian Diabetes, Obesity and Lifestyle study recruited adults aged ≥25 years old from across Australia. Participants were classified using an oral glucose tolerance test as having normal glucose tolerance (NGT), impaired glucose tolerance (IGT), impaired fasting glucose (IFG), known diabetes or newly diagnosed diabetes. Digital retinal photographs were taken of all participants with diabetes, IGT and IFG, and a sample of those with NGT, and graded for the presence of retinopathy. Retinal vascular calibre was measured from photographs by a computer-assisted method.

Results

Of the 1,998 participants with gradable retinal images, 16% had known diabetes, 17% newly diagnosed diabetes, 42% IGT, 6% IFG and 19% NGT. After multivariable adjustment, retinal arteriolar calibre was significantly larger in people with known diabetes (178.9 μm) compared with participants with NGT (174.6 μm, p = 0.02), IGT/IFG (175.5 μm, p = 0.02) or newly diagnosed diabetes (175.6 μm, p = 0.047). One SD increase in mean arteriolar calibre was associated with higher odds of diabetes compared with NGT (odds ratio [OR] = 1.28, 95%CI = 1.06–1.55). After multivariable adjustment, each SD increase in venular calibre was associated with higher odds of having retinopathy in persons with IGT/IFG (OR = 1.78, 95%CI = 1.36–2.34) or in persons with diabetes (OR = 1.68, 95%CI = 1.23–2.29).

Conclusions/interpretation

Diabetes is associated with larger retinal arteriolar calibre and retinopathy with larger retinal venular calibre. The contrasting associations may reflect different underlying pathophysiological processes in the natural history of diabetes.
Literature
1.
go back to reference Dunstan D, Zimmet P, Welborn T et al (2002) The rising prevalence of diabetes and impaired glucose tolerance. Diabetes Care 25:829–834CrossRef Dunstan D, Zimmet P, Welborn T et al (2002) The rising prevalence of diabetes and impaired glucose tolerance. Diabetes Care 25:829–834CrossRef
2.
go back to reference Zimmet P (1999) Diabetes epidemiology as a trigger to diabetes research. Diabetologia 42:499–518CrossRef Zimmet P (1999) Diabetes epidemiology as a trigger to diabetes research. Diabetologia 42:499–518CrossRef
3.
go back to reference Engelgau M, Narayan K, Herman W (2000) Screening for type 2 diabetes. Diabetes Care 23:1563–1580CrossRef Engelgau M, Narayan K, Herman W (2000) Screening for type 2 diabetes. Diabetes Care 23:1563–1580CrossRef
4.
go back to reference Mitchell P, Smith W, Wang J, Attebo K (1998) Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study. Ophthalmology 105:406–411CrossRef Mitchell P, Smith W, Wang J, Attebo K (1998) Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study. Ophthalmology 105:406–411CrossRef
5.
go back to reference Hubbard L, Brothers R, King W et al (1999) Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 106:2269–2280CrossRef Hubbard L, Brothers R, King W et al (1999) Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 106:2269–2280CrossRef
6.
go back to reference Wong TY, Knudtson MD, Klein R, Klein BE, Meuer SM, Hubbard LD (2004) Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology 111:1183–1190CrossRef Wong TY, Knudtson MD, Klein R, Klein BE, Meuer SM, Hubbard LD (2004) Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology 111:1183–1190CrossRef
7.
go back to reference Wong TY, Klein R, Sharrett AR et al (2002) Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA 287:2528–2533CrossRef Wong TY, Klein R, Sharrett AR et al (2002) Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA 287:2528–2533CrossRef
8.
go back to reference Wong TY, Shankar A, Klein R, Klein BE, Hubbard LD (2005) Retinal arteriolar narrowing, hypertension, and subsequent risk of diabetes mellitus. Arch Intern Med 165:1060–1065CrossRef Wong TY, Shankar A, Klein R, Klein BE, Hubbard LD (2005) Retinal arteriolar narrowing, hypertension, and subsequent risk of diabetes mellitus. Arch Intern Med 165:1060–1065CrossRef
9.
go back to reference Ikram MK, Janssen JA, Roos AM et al (2006) Retinal vessel diameters and risk of impaired fasting glucose or diabetes: the Rotterdam study. Diabetes 55:506–510CrossRef Ikram MK, Janssen JA, Roos AM et al (2006) Retinal vessel diameters and risk of impaired fasting glucose or diabetes: the Rotterdam study. Diabetes 55:506–510CrossRef
10.
go back to reference Klein R, Klein B, Moss S, Wong T, Sharrett AR (2006) Retinal vascular caliber in persons with type 2 diabetes. The Wisconsin Epidemiological Study of Diabetic Retinopathy: XX. Ophthalmology 113:1488–1498CrossRef Klein R, Klein B, Moss S, Wong T, Sharrett AR (2006) Retinal vascular caliber in persons with type 2 diabetes. The Wisconsin Epidemiological Study of Diabetic Retinopathy: XX. Ophthalmology 113:1488–1498CrossRef
11.
go back to reference Wong T, Shankar A, Klein R, Klein B (2004) Retinal vessel diameters and the incidence of gross proteinuria and renal insufficiency in people with type 1 diabetes. Diabetes 53:179–184CrossRef Wong T, Shankar A, Klein R, Klein B (2004) Retinal vessel diameters and the incidence of gross proteinuria and renal insufficiency in people with type 1 diabetes. Diabetes 53:179–184CrossRef
12.
go back to reference Nguyen T, Wong T (2006) Retinal vascular manifestations of metabolic disorders. Trends Endocrinol Metab 17:262–268CrossRef Nguyen T, Wong T (2006) Retinal vascular manifestations of metabolic disorders. Trends Endocrinol Metab 17:262–268CrossRef
13.
go back to reference Wong T, Barr E, Tapp R et al (2005) Retinopathy in persons with impaired glucose metabolism: the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Am J Ophthalmol 140:1157–1159CrossRef Wong T, Barr E, Tapp R et al (2005) Retinopathy in persons with impaired glucose metabolism: the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Am J Ophthalmol 140:1157–1159CrossRef
14.
go back to reference Diabetes Prevention Program Research Group (2007) The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet Med 24:137–144CrossRef Diabetes Prevention Program Research Group (2007) The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet Med 24:137–144CrossRef
15.
go back to reference Barr E, Wong T, Tapp R, Harper CA, Zimmett PZ, Atkins, R, Shaw JE, AusDiab Steering Committee (2006) Is peripheral neuropathy associated with retinopathy and albuminuria in individuals with impaired glucose metabolism? The 1999–2000 AusDiab. Diabetes Care 29:1114–1116CrossRef Barr E, Wong T, Tapp R, Harper CA, Zimmett PZ, Atkins, R, Shaw JE, AusDiab Steering Committee (2006) Is peripheral neuropathy associated with retinopathy and albuminuria in individuals with impaired glucose metabolism? The 1999–2000 AusDiab. Diabetes Care 29:1114–1116CrossRef
16.
go back to reference Dunstan D, Zimmet P, Welborn T et al (2002) The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)—methods and response rates. Diabetes Res Clin Pract 57:119–129CrossRef Dunstan D, Zimmet P, Welborn T et al (2002) The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)—methods and response rates. Diabetes Res Clin Pract 57:119–129CrossRef
17.
go back to reference Tapp R, McCarty D, Shaw J et al (2003) The prevalence and risk factors associated with diabetic retinopathy in the Australian population. Diabetes Care 26:1731–1737CrossRef Tapp R, McCarty D, Shaw J et al (2003) The prevalence and risk factors associated with diabetic retinopathy in the Australian population. Diabetes Care 26:1731–1737CrossRef
18.
go back to reference World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Department of Noncommunicable Disease Surveillance, Geneva World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Department of Noncommunicable Disease Surveillance, Geneva
19.
go back to reference Aldington S, Kohner E, Meuer S, Klein R, Sjolie A (1995) Methodology for retinal photography and assessment of diabetic retinopathy: EURODIAB IDDM Complications Study. Diabetologia 38:437–444CrossRef Aldington S, Kohner E, Meuer S, Klein R, Sjolie A (1995) Methodology for retinal photography and assessment of diabetic retinopathy: EURODIAB IDDM Complications Study. Diabetologia 38:437–444CrossRef
20.
go back to reference Wong TY, Knudtson MD, Klein R, Klein BE, Meuer SM, Hubbard LD (2004) Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology 111:1183–1190CrossRef Wong TY, Knudtson MD, Klein R, Klein BE, Meuer SM, Hubbard LD (2004) Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology 111:1183–1190CrossRef
21.
go back to reference Hubbard LD, Brothers RJ, King WN et al (1999) Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 106:2269–2280CrossRef Hubbard LD, Brothers RJ, King WN et al (1999) Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 106:2269–2280CrossRef
22.
go back to reference Knudtson MD, Lee KE, Hubbard LD, Wong TY, Klein R, Klein BE (2003) Revised formulas for summarizing retinal vessel diameters. Curr Eye Res 27:143–149CrossRef Knudtson MD, Lee KE, Hubbard LD, Wong TY, Klein R, Klein BE (2003) Revised formulas for summarizing retinal vessel diameters. Curr Eye Res 27:143–149CrossRef
23.
go back to reference Liew G, Sharrett AK, R, Klein R et al (2007) Measurement of retinal vascular caliber: issues and alternatives to using the arteriole to venule ratio. Invest Ophthalmol Vis Sci 48:52–57CrossRef Liew G, Sharrett AK, R, Klein R et al (2007) Measurement of retinal vascular caliber: issues and alternatives to using the arteriole to venule ratio. Invest Ophthalmol Vis Sci 48:52–57CrossRef
24.
go back to reference Knudtson MD, Klein BE, Klein R et al (2004) Variation associated with measurement of retinal vessel diameters at different points in the pulse cycle. Br J Ophthalmol 88:57–61CrossRef Knudtson MD, Klein BE, Klein R et al (2004) Variation associated with measurement of retinal vessel diameters at different points in the pulse cycle. Br J Ophthalmol 88:57–61CrossRef
25.
go back to reference Bulpitt C, Dollery C, Kohner E (1970) The marginal plasma zone in the retinal microcirculation. Cardiovasc Res 4:207–212CrossRef Bulpitt C, Dollery C, Kohner E (1970) The marginal plasma zone in the retinal microcirculation. Cardiovasc Res 4:207–212CrossRef
26.
go back to reference Wong T, Islam A, Klein R et al (2006) Retinal vascular caliber, cardiovascular risk factors, and inflammation: the Multi-Ethnic Study of Atherosclerosis (MESA). Invest Ophthalmol Vis Sci 47:2341–2350CrossRef Wong T, Islam A, Klein R et al (2006) Retinal vascular caliber, cardiovascular risk factors, and inflammation: the Multi-Ethnic Study of Atherosclerosis (MESA). Invest Ophthalmol Vis Sci 47:2341–2350CrossRef
27.
go back to reference Wong TY, Klein R, Sharrett AR et al (2002) Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA 287:2528–2533CrossRef Wong TY, Klein R, Sharrett AR et al (2002) Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA 287:2528–2533CrossRef
28.
go back to reference Wong TY, Shankar A, Klein R, Klein BE, Hubbard LD (2005) Retinal arteriolar narrowing, hypertension, and subsequent risk of diabetes mellitus. Arch Intern Med 165:1060–1065CrossRef Wong TY, Shankar A, Klein R, Klein BE, Hubbard LD (2005) Retinal arteriolar narrowing, hypertension, and subsequent risk of diabetes mellitus. Arch Intern Med 165:1060–1065CrossRef
29.
go back to reference Frederiksen C, Jeppesen P, Knudsen S, Poulsen P, Mogensen C, Bek T (2006) The blood pressure-induced diameter response of retinal arterioles decreases with increasing diabetic maculopathy. Graefes Arch Clin Exp Ophthalmol 244:1255–1261CrossRef Frederiksen C, Jeppesen P, Knudsen S, Poulsen P, Mogensen C, Bek T (2006) The blood pressure-induced diameter response of retinal arterioles decreases with increasing diabetic maculopathy. Graefes Arch Clin Exp Ophthalmol 244:1255–1261CrossRef
30.
go back to reference Stefansson E (1997) Ocular oxygenation and the treatment of diabetic retinopathy. Br J Ophthalmol 81:274–278CrossRef Stefansson E (1997) Ocular oxygenation and the treatment of diabetic retinopathy. Br J Ophthalmol 81:274–278CrossRef
31.
go back to reference Bek T (1999) Diabetic maculopathy caused by disturbances in retinal vasomotion. A new hypothesis. Acta Ophthalmol Scand 77:376–380CrossRef Bek T (1999) Diabetic maculopathy caused by disturbances in retinal vasomotion. A new hypothesis. Acta Ophthalmol Scand 77:376–380CrossRef
32.
go back to reference Kristinsson JK, Gottfredsdottir MS, Stefansson E (1997) Retinal vessel dilatation and elongation precedes diabetic macular oedema. Br J Ophthalmol 81:274–278CrossRef Kristinsson JK, Gottfredsdottir MS, Stefansson E (1997) Retinal vessel dilatation and elongation precedes diabetic macular oedema. Br J Ophthalmol 81:274–278CrossRef
33.
go back to reference Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Levison SW (2002) Diabetic retinopathy: more than meets the eye. Surv Ophthalmol 47(Suppl 2):S253–S262CrossRef Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Levison SW (2002) Diabetic retinopathy: more than meets the eye. Surv Ophthalmol 47(Suppl 2):S253–S262CrossRef
34.
go back to reference Klein R, Klein BE, Moss SE et al (2004) The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Opthalmol 122:76–83CrossRef Klein R, Klein BE, Moss SE et al (2004) The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Opthalmol 122:76–83CrossRef
35.
go back to reference Grunwald JE, Riva CE, Baine J, Brucker AJ (1992) Total retinal volumetric blood flow rate in diabetic patients with poor glycemic control. Invest Ophthalmol Vis Sci 33:356–363 Grunwald JE, Riva CE, Baine J, Brucker AJ (1992) Total retinal volumetric blood flow rate in diabetic patients with poor glycemic control. Invest Ophthalmol Vis Sci 33:356–363
36.
go back to reference Saldivar E, Cabrales P, Tsai AG, Intaglietta M (2003) Microcirculatory changes during chronic adaptation to hypoxia. Am J Physiol Heart Circ Physiol 285:H2064–H2071CrossRef Saldivar E, Cabrales P, Tsai AG, Intaglietta M (2003) Microcirculatory changes during chronic adaptation to hypoxia. Am J Physiol Heart Circ Physiol 285:H2064–H2071CrossRef
37.
go back to reference Ikram MK, de Jong FJ, Vingerling JR et al (2004) Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study. Invest Ophthalmol Vis Sci 45:2129–2134CrossRef Ikram MK, de Jong FJ, Vingerling JR et al (2004) Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study. Invest Ophthalmol Vis Sci 45:2129–2134CrossRef
38.
go back to reference Clermont A, Bursell S (2007) Retinal blood flow in diabetes. Microcirculation 14:49–61CrossRef Clermont A, Bursell S (2007) Retinal blood flow in diabetes. Microcirculation 14:49–61CrossRef
39.
go back to reference Caballero AE (2005) Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation. Arch Med Res 36:241–249CrossRef Caballero AE (2005) Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation. Arch Med Res 36:241–249CrossRef
Metadata
Title
The relationship of retinal vascular calibre to diabetes and retinopathy: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study
Authors
G. Tikellis
J. J. Wang
R. Tapp
R. Simpson
P. Mitchell
P. Z. Zimmet
J. Shaw
T. Y. Wong
Publication date
01-11-2007
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 11/2007
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-007-0822-x

Other articles of this Issue 11/2007

Diabetologia 11/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.